Cargando…

Recent first report of human-to-dog transmission of Monkeypox virus emphasizes an urgent need of enhancing surveillance and strengthen further explorative research to reveal its real magnitude of reverse zoonosis from other animals including pets as like that happened with SARS-CoV-2 / COVID-19 pandemic – Correspondence

Detalles Bibliográficos
Autores principales:	Sah, Ranjit, Hada, Vivek, Mohanty, Aroop, Alshahrani, Najim Z., Chakraborty, Sandip, Bhattacharya, Manojit, Chakraborty, Chiranjib, Dhama, Kuldeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IJS Publishing Group Ltd. Published by Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534089/ https://www.ncbi.nlm.nih.gov/pubmed/36174830 http://dx.doi.org/10.1016/j.ijsu.2022.106949

Ejemplares similares

A call for a novel and next-generation vaccine against monkeypox disease
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Appearance and re-appearance of zoonotic disease during the pandemic period: long-term monitoring and analysis of zoonosis is crucial to confirm the animal origin of SARS-CoV-2 and monkeypox virus
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Monkeypox reported in India – South East Asia Region: Health and economic challenges
por: Sah, Ranjit, et al.
Publicado: (2022)

Monkeypox in South-East Asia: Is an alarming bell for this region? – Correspondence
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Recently spreading human monkeypox virus infection and its transmission during COVID-19 pandemic period: A travelers' prospective
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Monkeypox virus vaccine evolution and global preparedness for vaccination
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Evolution, epidemiology, geographical distribution, and mutational landscape of newly emerging monkeypox virus
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

The Emergence of Monkeypox: A Global Health Threat
por: Sah, Ranjit, et al.
Publicado: (2022)

Recombinant SARS-CoV-2 variants XD, XE, and XF: The emergence of recombinant variants requires an urgent call for research – Correspondence
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Immediate need for next-generation and mutation-proof vaccine to protect against current emerging Omicron sublineages and future SARS-CoV-2 variants: An urgent call for researchers and vaccine companies – Correspondence
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Evaluation of differentially expressed genes during replication using gene expression landscape of monkeypox-infected MK2 cells: A bioinformatics and systems biology approach to understanding the genomic pattern of viral replication
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

Designing, characterization, and immune stimulation of a novel multi-epitopic peptide-based potential vaccine candidate against monkeypox virus through screening its whole genome encoded proteins: An immunoinformatics approach
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Recent outbreaks of hantavirus-a very lethal and zoonotic virus – An update and counteracting strategies
por: Sah, Ranjit, et al.
Publicado: (2022)

Cases of BA.2.75 and recent BA.2.75.2 subvariant of Omicron are increasing in India: Is it alarming at the global level?
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

Monkeypox vaccines and vaccination strategies: Current knowledge and advances. An update – Correspondence
por: Chakraborty, Sandip, et al.
Publicado: (2022)

Dengue virus and its recent outbreaks: current scenario and counteracting strategies
por: Sah, Ranjit, et al.
Publicado: (2023)

Artificial intelligence–enabled clinical trials might be a faster way to perform rapid clinical trials and counter future pandemics: lessons learned from the COVID-19 period
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects
por: Chakraborty, Sandip, et al.
Publicado: (2022)

Quantum computing on nucleic acid research: Approaching towards next-generation computing
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

Unexpected sudden rise of human monkeypox cases in multiple non-endemic countries amid COVID-19 pandemic and salient counteracting strategies: Another potential global threat?
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
por: Chatterjee, Srijan, et al.
Publicado: (2023)

A potential monkeypox pandemic: are we making the same mistakes as COVID-19?
por: Sah, Ranjit, et al.
Publicado: (2022)

Langya virus, a newly identified Henipavirus in China - Zoonotic pathogen causing febrile illness in humans, and its health concerns: Current knowledge and counteracting strategies – Correspondence
por: Chakraborty, Sandip, et al.
Publicado: (2022)

Marburg virus re-emerged in 2022: recently detected in Ghana, another zoonotic pathogen coming up amid rising cases of Monkeypox and ongoing COVID-19 pandemic- global health concerns and counteracting measures
por: Sah, Ranjit, et al.
Publicado: (2022)

Major sporting events amid monkeypox and COVID-19 outbreaks: Considering the impact upon the traveller
por: Sah, Ranjit, et al.
Publicado: (2022)

Advances in artificial intelligence (AI)-based diagnosis in clinical practice—correspondence
por: Chakraborty, Sandip, et al.
Publicado: (2023)

Artificial intelligence (AI) is paving the way for a critical role in drug discovery, drug design, and studying drug–drug interactions – correspondence
por: Chakraborty, Sandip, et al.
Publicado: (2023)

Organ-on-chip: a new paradigm for clinical trials – correspondence
por: Chopra, Hitesh, et al.
Publicado: (2023)

Omicron variant (B.1.1.529) of SARS-CoV-2: understanding mutations in the genome, S-glycoprotein, and antibody-binding regions
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Hybrid immunity against COVID-19 in different countries with a special emphasis on the Indian scenario during the Omicron period
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Can the RBD mutation R346X provide an additional fitness to the “variant soup,” including offspring of BQ and XBB of SARS-CoV-2 Omicron for the antibody resistance?
por: Chatterjee, Srijan, et al.
Publicado: (2023)

Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
por: Chatterjee, Srijan, et al.
Publicado: (2023)

Molnupiravir’s mechanism of action drives “error catastrophe” in SARS-CoV-2: A therapeutic strategy that leads to lethal mutagenesis of the virus
por: Chatterjee, Srijan, et al.
Publicado: (2023)

Human monkeypox: an emerging zoonosis
por: Di Giulio, Daniel B, et al.
Publicado: (2004)

Human Monkeypox: An Emerging Zoonosis
por: Giradkar, Janhvi, et al.
Publicado: (2022)

Are Saudi Healthcare Workers Willing to Receive the Monkeypox Virus Vaccine? Evidence from a Descriptive-Baseline Survey
por: Alarifi, Abdullah M., et al.
Publicado: (2023)

Monkeypox deaths in 2022 outbreak across the globe: correspondence
por: Sah, Ranjit, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_84ntgkabqvi42vjm9p4m648mtm